Dow rises on easing U.S.-Iran tensions

The move was broad enough to suggest investors were willing to look through near-term uncertainty. Healthcare shares were among the stronger groups, while software stocks also advanced, a sign that the market was rotating back toward growth and defensives at the same time. The Dow’s gain left the blue-chip index above its 50-day moving average, while the S&P 500 remained close to recent highs, with RSI readings still elevated enough to show a market that is recovering from fear rather than fully resetting.

For investors, the bigger takeaway is that geopolitical relief can unlock buying in high-quality names that had been sitting on the sidelines. Berkshire Hathaway topped an entry point Tuesday, giving long-term investors a rare chance to buy a fortress balance sheet, durable cash generation and insurance-linked resilience while the market is still nervous. That is exactly the sort of setup the market tends to miss in the early stages of a risk-on reversal.

The opportunity is not limited to Berkshire. If U.S.-Iran tensions continue to ease, the beneficiaries could include broader U.S. equities, consumer cyclicals and rate-sensitive growth stocks that get help from lower oil pressure and improved sentiment. The losers, by contrast, would be the usual geopolitical hedge trades — energy, defense and safe-haven flows — if the market decides escalation risk is fading.

The key question now is whether diplomacy can hold. If it does, this rally has room to extend beyond one headline-driven session as investors rotate from fear into quality, and from crisis hedges into stocks with real operating leverage. For now, the market is telling you to stay positioned for de-escalation — but keep a close eye on oil, because that remains the fastest way for this story to flip.